2022
DOI: 10.1007/978-3-031-08491-1_5
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic Resistance in Pseudomonas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
22
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(23 citation statements)
references
References 244 publications
1
22
0
Order By: Relevance
“…From whole-genome sequencing experiments of this pathogen, exposure to different classes of antibiotics (β-lactams, fluoroquinolones, and aminoglycosides) drives stress evolution, leading to the alarming CR level in the hospital setting [ 25 , 26 , 27 ]. The success of P. aeruginosa in colonizing different habitats largely relies on its metabolic versatility and robustness making it difficult to eradicate this pathogen from the nosocomial environment [ 28 ]. The complexity of this microorganism causes limitations in overcoming quinolone or carbapenem resistance with standard ASPs [ 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…From whole-genome sequencing experiments of this pathogen, exposure to different classes of antibiotics (β-lactams, fluoroquinolones, and aminoglycosides) drives stress evolution, leading to the alarming CR level in the hospital setting [ 25 , 26 , 27 ]. The success of P. aeruginosa in colonizing different habitats largely relies on its metabolic versatility and robustness making it difficult to eradicate this pathogen from the nosocomial environment [ 28 ]. The complexity of this microorganism causes limitations in overcoming quinolone or carbapenem resistance with standard ASPs [ 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Contrary to intrinsic resistance, the development of acquired resistance is highly influenced by external stressors, such as exposure to antibiotics. In the presence of such compounds, resistant bacteria present a selective advantage over susceptible strains; this way, the surviving bacteria will give rise to a resistant population [ 106 , 107 , 108 , 109 ].…”
Section: Antibiotic Resistancementioning
confidence: 99%
“…If its new traits are beneficial for the bacteria and contribute to its survival in adverse conditions, they will probably become predominant as they are transmitted to subsequent generations [ 110 ]. In P. aeruginosa , mutations can result in modifications of antibiotic targets or porin channels, and therefore in a reduced antibiotic uptake, or in the increased expression of resistance genes, and consequently in the overproduction of antibiotic-inactivating enzymes and multidrug efflux pumps [ 106 , 109 , 111 ].…”
Section: Antibiotic Resistancementioning
confidence: 99%
“…It is also a commensal bacterium transiently inhabiting the digestive tract and skin of humans and animals. Due to its high genomic plasticity and metabolic versatility, P. aeruginosa is able to colonize and cause infection in a wide range of hosts, from unicellular organisms to humans [ 1 , 2 , 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…The presence of diverse properties encoded in its genome, namely virulence and antimicrobial-resistant determinants, led to the classification of P. aeruginosa as a member of the ESKAPE group (amongst the Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , and Enterobacter species) [ 4 , 8 ]. The occurrence of multidrug-resistant (MDR) P. aeruginosa strains is a significant medical issue.…”
Section: Introductionmentioning
confidence: 99%